Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $8.18-$22.49 |
Market Cap | $1.6B |
Shares Short | 14M |
Financials
See moreRevenue (12 Mos) | $83.9M |
Revenue Growth (YoY) | 2.2% |
Gross Profit (12 Mos) | -$232.9M |
Diluted EPS | -$3.05 |
News
See moreYahoo Finance • 13 days ago
Stifel Raised Nurix Therapeutics, Inc. (NRIX) Price Target to $35 and Maintains Buy Ahead of 2026 Catalysts
Yahoo Finance • 2 months ago
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
Yahoo Finance • 2 months ago
Wells Fargo Reaffirms a Buy Rating on Nurix Therapeutics (NRIX), Sets a $30 PT
Yahoo Finance • 2 months ago
Cathie Wood tilts toward Robinhood, Bitcoin ETFs, trims Tesla, Iridium
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1600 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 317 |
